DUBLIN--(BUSINESS WIRE)--The "Smart Inhalers Market to 2027 - Global Analysis and Forecasts by Product; Disorder; End User and Geography" report has been added to ResearchAndMarkets.com's offering.
The global smart inhalers market is expected to reach US$ 8,033.21 Mn in 2027 from US$ 1,094.26 Mn in 2018. The smart inhalers market is estimated to grow with a CAGR of 25.5% from 2019-2027.
The market is driven by factors such as increasing levels of air pollution as well as a rise in smoking habits, rising prevalence of asthma, and COPD across the globe and growing geriatric population. However, risks associated with cyber threats and limited knowledge regarding the use of smart inhalers may limit the growth of the market to a certain extent.
Smart inhalers are used for the treatment of respiratory disorders such as asthma and COPD. With each inhalation with the help of an inhaler, the device delivers a decided amount of medication to the lungs. However, in practice, there is limited knowledge regarding the proper use of these inhalers for the management of asthma as well as COPD. Often have difficulty in adapting to the correct inhaler technique and, hence, receive insufficient medication. This applies equally to both metered dose inhalers (MDIs) as well as dry powder inhalers (DPIs), leading to poor disease control along with increased healthcare costs.
Studies reveal due to a patient's error in drug intake occur approximately 70 percent to 90 percent of the time, which results in only 7 percent to 40 percent of the drug being delivered to the lungs. An error related to the coordination between inhalation and the release of drugs through the drug is a commonly observed error among the patients. Even a short delay can lead to only 20 percent of the medication being delivered to the lungs.
Another significant error is not breathing deeply enough, which may cause another 10 percent loss of medication to reach the lungs. Improper inhalation technique causes decreased efficacy through reduced deposition of drug in the lungs, eventually leading to an increase in the rate of disease severity and therefore causing an increase in healthcare costs. Hence, the errors that occur due to improper use of inhalers for the management of asthma and COPD are expected to hinder the growth of the market in the future years.
Global smart inhalers were segmented by product, disorder, and end user. The product segment was segmented as inhalers and nebulizers. On the basis of the disorder, the market is categorized as asthma and chronic obstructive pulmonary disease (COPD). Based on the end user, the market was segmented as home-care settings and hospitals & clinics. During 2018, the home-care settings segment led the smart inhalers market by the end user.
Some of the major primary and secondary sources included in the report are Saudi Thoracic Society, Food and Drug Administration, The Asthma and Allergy Foundation of America, The Brazilian Institute of Geography and Statistics, The National Health Survey, and others.
Key Topics Covered
1.1 Scope Of The Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Smart Inhalers Market - By Product
1.3.2 Global Smart Inhalers Market - By Disorder
1.3.3 Global Smart Inhalers Market - By End User
1.3.4 Global Smart Inhalers Market - By Geography
2. Global Smart Inhalers Market - Key Takeaways
3. Research Methodology
3.2 Secondary Research
3.3 Primary Research
4. Global Smart Inhalers Market - Market Landscape
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
5. Global Smart Inhalers Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Levels Of Air Pollution As Well As Rise In The Smoking Habits
5.1.2 Rising Prevalence Of Asthma And COPD Across The Globe
5.1.3 Growing Geriatric Population
5.2 Key Market Restraints
5.2.1 Risks Associated With Cyber Threats
5.2.2 Limited Knowledge Regarding The Use Of Smart Inhalers
5.3 Key Market Opportunity
5.3.1 Growth In The Global Healthcare Market
5.4 Future Trend
5.4.1 Increasing Acceptance Of Mobile Health Technology
5.5 Impact Analysis
6. Smart Inhalers Market - Global Analysis
6.1 Global Smart Inhalers Market Revenue Forecasts And Analysis
6.2 Global Smart Inhalers Market, By Geography - Forecasts And Analysis
6.3 Performance Of Key Players
6.3.1 Novartis AG
6.3.2 GlaxoSmithKline plc.
7. Global Smart Inhalers Market Analysis- By Product
7.2 Global Smart Inhalers Market, By Product 2018 & 2027 (%)
7.3 Inhalers Market
7.3.2 Global Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)
7.4 Nebulizers Market
7.4.2 Global Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)
8. Global Smart Inhalers Market Analysis- By Disorder
8.2 Global Smart Inhalers Market, By Disorder 2018 & 2027 (%)
8.3 Asthma Market
8.3.2 Global Asthma Market Revenue And Forecasts To 2027 (US$ Mn)
8.4 Chronic Obstructive Pulmonary Disease Market
8.4.2 Global Chronic Obstructive Pulmonary Disease Market Revenue And Forecasts To 2027 (US$ Mn)
9. Global Smart Inhalers Market Analysis- By End User
9.2 Global Smart Inhalers Market, By End User 2018 & 2027 (%)
9.3 Hospitals & Clinics Market
9.3.2 Global Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
9.4 Home Care Settings Market
9.4.2 Global Home Care Settings Market Revenue And Forecasts To 2027 (US$ Mn)
10. Smart Inhalers Market Revenue And Forecasts To 2027 - Geographical Analysis
10.1 North America Smart Inhalers Market Revenue And Forecasts To 2027
10.2 Europe Smart Inhalers Market Revenue And Forecasts To 2027
10.3 Asia Pacific Smart Inhalers Market Revenue And Forecasts To 2027
10.4 Middle East & Africa Smart Inhalers Market Revenue And Forecasts To 2027
10.5 South And Central America Smart Inhalers Market Revenue And Forecasts To 2027
11. Smart Inhalers Market- Industry Landscape
11.2 Comparative Company Analysis
11.3 Growth Strategies Done By The Companies In The Market, (%)
11.4 Organic Developments
11.5 Inorganic Developments
12. Smart Inhalers Market-Key Company Profiles
12.1 GlaxoSmithKline PLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Adherium Limited
12.3 Novartis AG
12.4 Vectura Group PLC
12.5 Cohero Health Inc.
12.6 Crux Product Design Ltd
12.7 Findair Sp. Z O. O.
12.8 Teva Pharmaceutical Industries Ltd.
12.10 Amiko Digital Health Limited
For more information about this report visit https://www.researchandmarkets.com/r/x3sz2j